UNH
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated historical holders
total: 37
Appaloosa Management UnitedHealth Group Incorporated transactions over time
- Total transactions:
- 28
- New positions:
- 1
- Added:
- 10
- Reduced:
- 17
- Held since:
- 2017 Q1
- Held for:
- 37 quarters
- Latest activity:
- 2026 Q1
David Tepper has been an institutional investor in UnitedHealth Group Incorporated (UNH) since 2017 Q1. According to 2026 Q1 report, David Tepper holds 90,000 shares with a market value of roughly $24.35M representing 0.41% of their equity portfolio. The fund/company first acquired UNH in 2017 Q1, initially purchasing 300,000 shares. Since the initial investment, Appaloosa Management has made 27 more transactions in this position.
Does David Tepper still hold UNH?
Yes, David Tepper continues to hold UnitedHealth Group Incorporated (UNH). According to their 2026 Q1 report, they maintain a position of 90,000 shares valued at approximately $24.35M, representing 0.41% of their equity portfolio.
When did David Tepper first invest in UNH?
David Tepper first invested in UnitedHealth Group Incorporated (UNH) in 2017 Q1 at the reported quarter-end price of $164.01 per share, acquiring 300,000 shares in their initial purchase.
What is David Tepper's average cost basis for UNH?
Based on historical transaction data, David Tepper's estimated cost basis for UnitedHealth Group Incorporated (UNH) is approximately $286.27 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $286.27
- Weighted AVG sell price:
- $325.09
UNH transactions history by Appaloosa Management
28 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.41%
|
90,000
|
$270.59
|
$24,353,100
|
-55.00% (-110,000)
|
-0.43%
|
|
2025 Q4
|
0.96%
|
200,000
|
$330.11
|
$66,022,000
|
-1.72% (-3,500)
|
-0.02%
|
|
2025 Q3
|
0.95%
|
203,500
|
$345.30
|
$70,268,550
|
-91.69% (-2,246,500)
|
-12.03%
|
|
2025 Q2
|
11.85%
|
2,450,000
|
$311.97
|
$764,326,500
|
+1,300.00% (+2,275,000)
|
+11.01%
|
|
2025 Q1
|
1.65%
|
175,000
|
$523.75
|
$91,656,250
|
+0.29% (+500)
|
+0%
|
|
2024 Q3
|
1.52%
|
174,500
|
$584.68
|
$102,026,660
|
-5.68% (-10,500)
|
-0.1%
|
|
2024 Q2
|
1.53%
|
185,000
|
$509.26
|
$94,213,100
|
-7.50% (-15,000)
|
-0.11%
|
|
2023 Q2
|
1.78%
|
200,000
|
$480.64
|
$96,128,000
|
+33.33% (+50,000)
|
+0.45%
|
|
2022 Q2
|
4.84%
|
150,000
|
$513.63
|
$77,045,000
|
-10.71% (-18,000)
|
-0.37%
|
|
2022 Q1
|
3.43%
|
168,000
|
$509.97
|
$85,675,000
|
-6.15% (-11,000)
|
-0.14%
|
|
2021 Q3
|
1.67%
|
$390.74
|
-4.28% (-8,000)
|
|||
|
2021 Q2
|
1.55%
|
$400.44
|
-32.61% (-90,500)
|
|||
|
2021 Q1
|
1.48%
|
$372.07
|
+38.75% (+77,500)
|
|||
|
2020 Q4
|
1.05%
|
$350.68
|
+183.69% (+129,500)
|
|||
|
2020 Q3
|
0.39%
|
$311.77
|
-47.78% (-64,500)
|
|||
|
2020 Q2
|
0.69%
|
$294.95
|
-46.00% (-115,000)
|
|||
|
2020 Q1
|
1.91%
|
$249.38
|
-16.67% (-50,000)
|
|||
|
2019 Q4
|
2.22%
|
$293.98
|
+20.00% (+50,000)
|
|||
|
2019 Q3
|
1.59%
|
$217.32
|
-25.37% (-85,000)
|
|||
|
2019 Q2
|
3.44%
|
$244.01
|
+34.00% (+85,000)
|
|||
|
2018 Q4
|
3.08%
|
$249.12
|
-28.34% (-98,890)
|
|||
|
2018 Q3
|
1.63%
|
$266.04
|
-34.10% (-180,500)
|
|||
|
2018 Q2
|
1.49%
|
$245.34
|
-25.08% (-177,199)
|
|||
|
2018 Q1
|
1.56%
|
$214.00
|
+19.44% (+115,000)
|
|||
|
2017 Q4
|
1.24%
|
$220.46
|
-11.57% (-77,411)
|
|||
|
2017 Q3
|
1.90%
|
$195.85
|
+43.25% (+202,000)
|
|||
|
2017 Q2
|
1.29%
|
$185.42
|
+55.67% (+167,000)
|
|||
|
2017 Q1
|
0.86%
|
$164.01
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.